• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类癌症中遗传和表观遗传改变的原因和后果。

Cause and consequences of genetic and epigenetic alterations in human cancer.

机构信息

Department of Pediatric Laboratory Medicine, Hospital for Sick Children, Toronto, Canada;

出版信息

Curr Genomics. 2008 Sep;9(6):394-408. doi: 10.2174/138920208785699580.

DOI:10.2174/138920208785699580
PMID:19506729
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2691666/
Abstract

Both genetic and epigenetic changes contribute to development of human cancer. Oncogenomics has primarily focused on understanding the genetic basis of neoplasia, with less emphasis being placed on the role of epigenetics in tumourigenesis. Genomic alterations in cancer vary between the different types and stages, tissues and individuals. Moreover, genomic change ranges from single nucleotide mutations to gross chromosomal aneuploidy; which may or may not be associated with underlying genomic instability. Collectively, genomic alterations result in widespread deregulation of gene expression profiles and the disruption of signalling networks that control proliferation and cellular functions. In addition to changes in DNA and chromosomes, it has become evident that oncogenomic processes can be profoundly influenced by epigenetic mechanisms. DNA methylation is one of the key epigenetic factors involved in regulation of gene expression and genomic stability, and is biologically necessary for the maintenance of many cellular functions. While there has been considerable progress in understanding the impact of genetic and epigenetic mechanisms in tumourigenesis, there has been little consideration of the importance of the interplay between these two processes. In this review we summarize current understanding of the role of genetic and epigenetic alterations in human cancer. In addition we consider the associated interactions of genetic and epigenetic processes in tumour onset and progression. Furthermore, we provide a model of tumourigenesis that addresses the combined impact of both epigenetic and genetic alterations in cancer cells.

摘要

遗传和表观遗传变化共同导致人类癌症的发生。肿瘤基因组学主要侧重于了解肿瘤发生的遗传基础,而对表观遗传在肿瘤发生中的作用重视不够。癌症中的基因组改变在不同类型、不同阶段、不同组织和不同个体之间存在差异。此外,基因组改变范围从单个核苷酸突变到染色体大片段非整倍体;这些改变可能与潜在的基因组不稳定性有关,也可能没有关系。总的来说,基因组改变导致基因表达谱的广泛失调,并破坏了控制增殖和细胞功能的信号网络。除了 DNA 和染色体的改变外,人们已经明显认识到,肿瘤发生过程可以受到表观遗传机制的深刻影响。DNA 甲基化是参与基因表达和基因组稳定性调控的关键表观遗传因素之一,对于维持许多细胞功能是必不可少的。虽然人们在理解遗传和表观遗传机制在肿瘤发生中的作用方面取得了相当大的进展,但对这两个过程之间相互作用的重要性却很少考虑。在这篇综述中,我们总结了遗传和表观遗传改变在人类癌症中的作用的现有认识。此外,我们还考虑了遗传和表观遗传过程在肿瘤发生和进展中的相关相互作用。此外,我们提供了一个肿瘤发生模型,该模型考虑了癌细胞中表观遗传和遗传改变的综合影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cc7/2691666/7957bc154d14/CG-9-394_F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cc7/2691666/50f28d5d1c1f/CG-9-394_F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cc7/2691666/7957bc154d14/CG-9-394_F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cc7/2691666/50f28d5d1c1f/CG-9-394_F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cc7/2691666/7957bc154d14/CG-9-394_F2.jpg

相似文献

1
Cause and consequences of genetic and epigenetic alterations in human cancer.人类癌症中遗传和表观遗传改变的原因和后果。
Curr Genomics. 2008 Sep;9(6):394-408. doi: 10.2174/138920208785699580.
2
Epigenomics in stress tolerance of plants under the climate change.植物在气候变化下的应激耐受中的表观基因组学。
Mol Biol Rep. 2023 Jul;50(7):6201-6216. doi: 10.1007/s11033-023-08539-6. Epub 2023 Jun 9.
3
The epigenetic origin of aneuploidy.非整倍体的表观遗传学起源。
Curr Genomics. 2008 Mar;9(1):43-50. doi: 10.2174/138920208783884883.
4
Unraveling the Progression of Colon Cancer Pathogenesis Through Epigenetic Alterations and Genetic Pathways.通过表观遗传改变和遗传途径揭示结肠癌发病机制的进展
Cureus. 2024 May 2;16(5):e59503. doi: 10.7759/cureus.59503. eCollection 2024 May.
5
Epigenetic regulation in cancer progression.癌症进展中的表观遗传调控。
Cell Biosci. 2014 Aug 19;4:45. doi: 10.1186/2045-3701-4-45. eCollection 2014.
6
Epigenetics and cancer, 2nd IARC meeting, Lyon, France, 6 and 7 December 2007.表观遗传学与癌症,第二届国际癌症研究机构会议,法国里昂,2007年12月6日至7日
Mol Oncol. 2008 Jun;2(1):33-40. doi: 10.1016/j.molonc.2008.03.005. Epub 2008 Mar 27.
7
Interplay between Epigenetics and Genetics in Cancer.癌症中表观遗传学与遗传学的相互作用。
Genomics Inform. 2013 Dec;11(4):164-73. doi: 10.5808/GI.2013.11.4.164. Epub 2013 Dec 31.
8
Methylation of DNA in cancer.癌症中的 DNA 甲基化。
Adv Clin Chem. 2010;52:145-67. doi: 10.1016/s0065-2423(10)52006-7.
9
Epigenetic drivers and genetic passengers on the road to cancer.癌症发展过程中的表观遗传驱动因素和基因乘客因素
Mutat Res. 2008 Jul 3;642(1-2):1-13. doi: 10.1016/j.mrfmmm.2008.03.002. Epub 2008 Mar 25.
10
An Epigenetic Perspective on Intra-Tumour Heterogeneity: Novel Insights and New Challenges from Multiple Fields.肿瘤内异质性的表观遗传学视角:多领域的新见解与新挑战
Cancers (Basel). 2021 Oct 3;13(19):4969. doi: 10.3390/cancers13194969.

引用本文的文献

1
Pan-Cancer Analysis Identifies a Ras-Related GTPase as a Potential Modulator of Cancer.泛癌分析确定一种Ras相关GTP酶为癌症的潜在调节因子。
Int J Mol Sci. 2025 May 6;26(9):4419. doi: 10.3390/ijms26094419.
2
Breast cancer histopathology, classification and clinical management: Current perspectives.乳腺癌组织病理学、分类及临床管理:当前观点
Bioinformation. 2024 Dec 31;20(12):2069-2079. doi: 10.6026/9732063002002069. eCollection 2024.
3
Epigenomic insights and computational advances in hematologic malignancies.血液系统恶性肿瘤的表观基因组学见解与计算进展

本文引用的文献

1
Epigenetic contributions to cancer metastasis.表观遗传学对癌症转移的影响。
Clin Exp Metastasis. 2009;26(1):5-18. doi: 10.1007/s10585-008-9166-2. Epub 2008 Apr 2.
2
Genomic DNA hypomethylation as a biomarker for bladder cancer susceptibility in the Spanish Bladder Cancer Study: a case-control study.在西班牙膀胱癌研究中,基因组DNA低甲基化作为膀胱癌易感性的生物标志物:一项病例对照研究。
Lancet Oncol. 2008 Apr;9(4):359-66. doi: 10.1016/S1470-2045(08)70038-X. Epub 2008 Mar 12.
3
[Mutation of the RET proto-oncogene in type 2A multiple endocrine neoplasia Chinese families and the application of pentagastrin stimulation test in diagnosis and follow-up].
Mol Cytogenet. 2025 Apr 12;18(1):9. doi: 10.1186/s13039-025-00712-9.
4
A Comprehensive Review of Current Approaches in Bladder Cancer Treatment.膀胱癌治疗当前方法的综合综述
ACS Pharmacol Transl Sci. 2025 Jan 6;8(2):286-307. doi: 10.1021/acsptsci.4c00663. eCollection 2025 Feb 14.
5
Discovery of paradoxical genes: reevaluating the prognostic impact of overexpressed genes in cancer.矛盾基因的发现:重新评估癌症中过表达基因的预后影响。
Front Cell Dev Biol. 2025 Jan 22;13:1525345. doi: 10.3389/fcell.2025.1525345. eCollection 2025.
6
Molecular pathways in reproductive cancers: a focus on prostate and ovarian cancer.生殖系统癌症中的分子通路:聚焦前列腺癌和卵巢癌
Cancer Cell Int. 2025 Feb 3;25(1):33. doi: 10.1186/s12935-025-03658-5.
7
Unlocking the epigenetic code: new insights into triple-negative breast cancer.解开表观遗传密码:三阴性乳腺癌的新见解
Front Oncol. 2024 Dec 18;14:1499950. doi: 10.3389/fonc.2024.1499950. eCollection 2024.
8
Identification of epigenetic silencing of the SFRP2 gene in colorectal cancer as a clinical biomarker and molecular significance.鉴定结直肠癌中 SFRP2 基因的表观遗传沉默作为临床生物标志物的分子意义。
J Transl Med. 2024 May 27;22(1):509. doi: 10.1186/s12967-024-05329-x.
9
UBE2C: A pan-cancer diagnostic and prognostic biomarker revealed through bioinformatics analysis.UBE2C:通过生物信息学分析发现的一种泛癌诊断和预后生物标志物。
Cancer Rep (Hoboken). 2024 Apr;7(4):e2032. doi: 10.1002/cnr2.2032.
10
Development of Potent Dual BET/HDAC Inhibitors via Pharmacophore Merging and Structure-Guided Optimization.通过药效团融合和结构导向优化开发有效的双 BET/HDAC 抑制剂。
ACS Chem Biol. 2024 Feb 16;19(2):266-279. doi: 10.1021/acschembio.3c00427. Epub 2024 Jan 31.
[2A型多发性内分泌腺瘤中国家系中RET原癌基因的突变及五肽胃泌素刺激试验在诊断和随访中的应用]
Zhonghua Nei Ke Za Zhi. 2007 Nov;46(11):914-8.
4
Genome-wide mapping and characterization of hypomethylated sites in human tissues and breast cancer cell lines.人类组织和乳腺癌细胞系中低甲基化位点的全基因组图谱绘制与特征分析。
Genome Res. 2008 May;18(5):791-801. doi: 10.1101/gr.070961.107. Epub 2008 Feb 6.
5
Genome instability: a mechanistic view of its causes and consequences.基因组不稳定:对其原因及后果的机制性观点。
Nat Rev Genet. 2008 Mar;9(3):204-17. doi: 10.1038/nrg2268.
6
Retinoblastoma tumor suppressor protein-dependent methylation of histone H3 lysine 27 is associated with irreversible cell cycle exit.视网膜母细胞瘤肿瘤抑制蛋白依赖性组蛋白H3赖氨酸27甲基化与不可逆的细胞周期退出相关。
J Cell Biol. 2007 Dec 31;179(7):1399-412. doi: 10.1083/jcb.200705051.
7
High-resolution mapping of DNA hypermethylation and hypomethylation in lung cancer.肺癌中DNA高甲基化和低甲基化的高分辨率图谱
Proc Natl Acad Sci U S A. 2008 Jan 8;105(1):252-7. doi: 10.1073/pnas.0710735105. Epub 2007 Dec 27.
8
DNA methylation-dependent regulation of BORIS/CTCFL expression in ovarian cancer.DNA甲基化依赖性调控卵巢癌中BORIS/CTCFL的表达
Cancer Immun. 2007 Dec 21;7:21.
9
Genome-wide H3K9 histone acetylation profiles are altered in benzopyrene-treated MCF7 breast cancer cells.在苯并芘处理的MCF7乳腺癌细胞中,全基因组H3K9组蛋白乙酰化谱发生改变。
J Biol Chem. 2008 Feb 15;283(7):4051-60. doi: 10.1074/jbc.M707506200. Epub 2007 Dec 7.
10
Global DNA hypomethylation in liver cancer cases and controls: a phase I preclinical biomarker development study.肝癌病例与对照中的全基因组DNA低甲基化:一项I期临床前生物标志物开发研究。
Epigenetics. 2007 Oct-Dec;2(4):223-6. doi: 10.4161/epi.2.4.5214. Epub 2007 Oct 29.